OUTPATIENT CO-MANAGEMENT OF THE PATIENT RECEIVING ORAL RITODRINE THERAPY

Authors

  • Judith T. Fullerton PhD,

    Corresponding author
    1. Judith T. Fullerton, CNM, PhD, received her BSN from Wayne State University, her MS and Certificate in Nurse-Midwifery from Columbia, and PhD in Health Education (Health Administration tract) from Temple University. She currently is Associate Clinical Professor, University of California, San Diego, School of Medicine, and UCSD Coordinator of the UCSF/UCSD Intercampus Graduate Studies, which offers a program of nurse-midwifery studies.
    Search for more papers by this author
  • Mary K. Barger CNM, MPH

    1. Mary K. Barger, CNM, MPH, received her BSN from Stanford University, and her MPH and Certificate in Nurse-Midwifery from the Johns Hopkins University. She currently is Assistant Clinical Professor, UCSD School of Medicine, UCSF/UCSD Intercampus Graduate Studies nurse-midwifery educational program.
    Search for more papers by this author

UCSF/UCSD Intercampus Graduate Studies, Department of Community and Family Medicine, T-009, University of California, San Diego, La Jolla, CA, 92093.

ABSTRACT

The physiologic rationale for historic and contemporary management of preterm labor therapies are reviewed. A protocol, with rationale, for nurse-midwifery comanagement of patients receiving ritodrine hydrochloride (Yutopar) as outpatient therapy is presented. Implications for patient education are discussed.

Ancillary